Technology

Webinar Date/Time: Wednesday, May 24th, 2023 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST

Webinar Date/Time: Tuesday, March 14 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

Webinar Date/Time: Wed, Apr 12, 2023 1:00 PM EDT

Their integration across enterprise remains pivotal driver for success.

Biopharma insiders believe it’s time to invest in technology again.

Webinar Date/Time: Tuesday, February 28, 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

Webinar Date/Time: Tuesday, February 14, 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.

Better technology is redefining pharmacovigilance as it expands beyond its traditional compliance focus to become a key business differentiator.

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST

Webinar Date/Time: Thu, Dec 8, 2022 2:00 PM EST

Webinar Date/Time: Tuesday, Dec 6, 2022, 11am PT | 2pm ET

Webinar Date/Time: Wednesday, November 30, 2022, 1 pm EDT

AI drives new signal-detection efforts in Alzheimer’s and ALS.

Jay Duker, MD, spoke with Pharm Exec about advancements in ocular drug delivery.

Life sciences companies a likely targets of these kinds of attacks.

Indu Navar, founder of Everything ALS, speaks with Pharm Exec about how she lost her husband to the disease and how she's trying to improve the way its diagnosed.

The two technologies are helping HCPs spread information and collect data in new ways.

U.S. patent law will have to adapt to the use of AI in the life sciences industry.

The technology is not just about digital enablement anymore.

Jason Smith discusses his work with AI-based data platforms.

Anderson speaks about his work with new technology and platforms.

New MMIT research highlights payers’ continued hesitancy toward PDTs. Here’s what manufacturers need to know.